View in EDS

NY-ESO-1 and PD-L1 as biomarkers associated with nivolumab response and outcome in unresectable or recurrent esophageal squamous cell carcinoma: a multicenter biomarker study.

Saved in:
Bibliographic Details
Title: NY-ESO-1 and PD-L1 as biomarkers associated with nivolumab response and outcome in unresectable or recurrent esophageal squamous cell carcinoma: a multicenter biomarker study.
Authors: Nakai S; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan., Makino T; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan. tmakino@gesurg.med.osaka-u.ac.jp., Momose K; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan., Yamashita K; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan., Tanaka K; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan., Miyata H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Yamamoto S; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan., Motoori M; Department of Surgery, Osaka General Medical Center, Osaka, Japan., Kimura Y; Department of Gastroenterological Surgery, Kindai University Nara Hospital, Nara, Japan., Takeoka T; Department of Surgery, Sakai City Medical Center, Osaka, Japan., Hirao M; Department of Surgery, NHO Osaka National Hospital, Osaka, Japan., Matsuyama J; Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Osaka, Japan., Akamaru Y; Department of Surgery, Osaka Rosai Hospital, Osaka, Japan., Kurokawa Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan., Morii E; Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan., Eguchi H; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan., Doki Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 May 12. Date of Electronic Publication: 2026 May 12.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0851
DOI:10.1007/s00262-026-04415-x